Mutually_RB
exclusive_JJ
interaction_NN
of_IN
a_DT
novel_JJ
matrix_NN
attachment_NN
region_NN
binding_NN
protein_NN
and_CC
the_DT
NF-muNR_NN
enhancer_NN
repressor_NN
._.

Implications_NNS
for_IN
regulation_NN
of_IN
immunoglobulin_NN
heavy_JJ
chain_NN
expression_NN
._.

The_DT
immunoglobulin_NN
heavy_JJ
chain_NN
-LRB-_-LRB-
IgH_NN
-RRB-_-RRB-
intronic_JJ
enhancer_NN
stimulates_VBZ
transcription_NN
from_IN
functional_JJ
promoters_NNS
in_IN
B_NN
lymphocytes_NNS
but_CC
not_RB
other_JJ
cell_NN
types_NNS
._.

The_DT
observation_NN
that_IN
binding_NN
sites_NNS
for_IN
the_DT
nuclear_JJ
factor-mu_NN
negative_JJ
regulator_NN
-LRB-_-LRB-
NF-muNR_NN
-RRB-_-RRB-
enhancer_NN
repressor_NN
overlap_VBP
nuclear_JJ
matrix_NN
attachment_NN
regions_NNS
-LRB-_-LRB-
MARs_NNS
-RRB-_-RRB-
in_IN
this_DT
enhancer_NN
has_VBZ
lead_VBN
to_TO
the_DT
hypothesis_NN
that_IN
the_DT
cell_NN
type_NN
specificity_NN
of_IN
the_DT
enhancer_NN
might_MD
be_VB
controlled_VBN
by_IN
regulating_VBG
nuclear_JJ
matrix_NN
attachment_NN
-LRB-_-LRB-
Scheuermann_NNP
,_,
R._NNP
H._NNP
,_,
and_CC
Chen_NNP
,_,
U._NNP
-LRB-_-LRB-
1989_CD
-RRB-_-RRB-
Genes_NNS
&_NNP
Dev_NNP
._.
3_CD
,_,
1255-1266_CD
-RRB-_-RRB-
._.

To_TO
understand_VB
the_DT
role_NN
of_IN
MARs_NNS
in_IN
IgH_NN
enhancer_NN
regulation_NN
,_,
we_PRP
have_VBP
identified_VBN
a_DT
novel_JJ
MAR-binding_JJ
protein_NN
,_,
MAR-BP1_NN
,_,
from_IN
soluble_JJ
nuclear_JJ
matrix_NN
preparations_NNS
based_VBN
on_IN
its_PRP$
ability_NN
to_TO
bind_VB
to_TO
the_DT
MARs_NNS
associated_VBN
with_IN
the_DT
IgH_NN
enhancer_NN
._.

Purified_VBN
MAR-BP1_NN
migrates_VBZ
as_IN
a_DT
33-kDa_JJ
protein_NN
,_,
and_CC
it_PRP
can_MD
be_VB
found_VBN
in_IN
nuclear_JJ
matrix_NN
preparations_NNS
from_IN
a_DT
number_NN
of_IN
different_JJ
types_NNS
of_IN
lymphoid_JJ
cell_NN
lines_NNS
._.

Although_IN
specific_JJ
binding_NN
sites_NNS
have_VBP
been_VBN
difficult_JJ
to_TO
localize_VB
by_IN
chemical_JJ
or_CC
enzymatic_JJ
footprinting_NN
procedures_NNS
,_,
NF-muNR_NN
binding_NN
sites_NNS
are_VBP
critical_JJ
for_IN
efficient_JJ
MAR-BP1_NN
binding_NN
._.

Indeed_RB
,_,
binding_NN
of_IN
the_DT
IgH_JJ
enhancer_NN
to_TO
either_CC
intact_JJ
nuclear_JJ
matrix_NN
preparations_NNS
or_CC
to_TO
MAR-BP1_NN
is_VBZ
mutually_RB
exclusive_JJ
to_TO
NF-muNR_NN
binding_NN
._.

These_DT
results_NNS
are_VBP
consistent_JJ
with_IN
a_DT
model_NN
for_IN
cell-type_NN
specific_JJ
regulation_NN
in_IN
which_WDT
binding_NN
of_IN
the_DT
NF-muNR_NN
repressor_NN
to_TO
the_DT
IgH_NN
enhancer_NN
prevents_VBZ
nuclear_JJ
matrix_NN
attachment_NN
in_IN
inappropriate_JJ
cells_NNS
by_IN
interfering_VBG
with_IN
MAR-BP1_NN
\/_:
enhancer_NN
interaction_NN
._.

